Page 8 - Centric Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sanofi s IT hiring activity rises by 41 2% in April 2022

Sanofi s IT hiring activity rises by 41 2% in April 2022
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

United statesCentric services forNetwork administratorsWeb developersSample servicesJob analyticsMiscellaneous computer occupationsCentral americaEntry levelCentric servicesAlternate site clinical trialsClinical supplyBiological sample

Australia s pharma industry IT recruitment activity drops 12 1% in April 2022

Australia s pharma industry IT recruitment activity drops 12 1% in April 2022
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Ramsay health careCentric services forNetwork administratorsWeb developersMinistry of healthSample servicesJob analyticsMiscellaneous computer occupationsInformation analystsNew south walesEntry levelCentric servicesAlternate site clinical trialsClinical supplyBiological sample

Kintara activates first European site of Phase II/III glioblastoma trial

Kintara Therapeutics has activated the first European site of the VAL-083 treatment arm in the Phase II/III trial for treating glioblastoma.

Robert hoffmanCentric services forUniversity hospital zurichGlobal coalition for adaptive researchNational cancer instituteContract research organisation for clinical trialsKintara therapeuticsGlobal coalitionAdaptive researchResearch organisationCentric servicesAlternate site clinical trialsRegulatory consultation

Corcept terminates Phase III pancreatic ductal adenocarcinoma trial

Apart from pancreatic ductal adenocarcinoma, studies in liver disease, venous leg ulcer, sleep apnoea, and ocular issues are also reviewed.

Mediwound escharexCentric services forLaboratory equipmentDrug processing technologyFormosa pharmaceuticalsPipeline movesCorcept therapeuticsTrials arenaPhase transition success rateProcessing technologyPreference management solutionCentric servicesAlternate site clinical trials

Humanetics extends long COVID drug trial to more sites

Humanetics has expanded clinical trial of a new oral drug, BIO 300, for long-haul Covid-19 (long COVID) to include two more US study sites.

New yorkUnited statesMichael kaytorCentric services forHouston methodist research instituteNational institute of allergyNational institutes of healthSaas platform decentralizing clinical research at scaleHumanetics researchHumanetics corporationSample servicesMontefiore medical centerUs department of defenseMedical centerTexas health science centerHouston methodist research